Simplify Logo

Full-Time

Biomanufacturing Associate III

Confirmed live in the last 24 hours

ElevateBio

ElevateBio

201-500 employees

Develops and manufactures cell and gene therapies

Healthcare
Biotechnology

Mid, Senior

Waltham, MA, USA

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Required Skills
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in biological science(s) field or related engineering w/4-8 years of experience in cGMP biotech manufacturing preferred.
  • High school equivalency w/6-10 years of experience in cGMP biotech manufacturing.
  • 4-8 years of experience in cGMP biotech manufacturing.
  • 2-6 years of Cell Therapy/Viral Vector/mRNA manufacturing experience.
  • Outstanding communication skills (verbal and written).
  • Excellent computer and word processing skills including Microsoft Excel, PowerPoint, and Word.
  • Demonstrate proficiency in aseptic technique and/or processing.
  • Willingness to cross-train in cell therapy manufacturing.
Responsibilities
  • Routine right-first-time cGMP manufacturing of viral vectors and mRNA including but not limited to upstream, downstream, and aseptic fill finish and processing.
  • Perform manufacturing/operations start-up activities including but not limited to authoring SOPs, batch records, reports, risk assessments, material ordering/management.
  • Provide constructive input on teams for the selection and set-up of equipment, process, and material flows, etc.
  • Create and maintain training materials and curricula that support continuous improvement in the cGMP manufacture of viral vectors and mRNA.
  • Work effectively with cross functional teams comprised of process sciences, development, facilities & engineering, tech ops, quality control, quality assurance, to ensure right-first-time technology transfer.
  • Work closely with Quality Assurance and Process Sciences to proactively resolve issues such as deviations, CAPAs, Change Controls.
  • Commitment to the highest safety and quality standards in service of our colleagues and patients.
  • Generate and manage batch records, run reports, batch data, etc. for manufacturing and scale-up activities.
  • Proactively identify opportunities for improvements in process, safety, quality, and cost.

ElevateBio focuses on biotechnology, specifically in the cell and gene therapy market. They use proprietary technologies like gene editing and induced pluripotent stem cells (iPSC) to develop and manufacture therapies. Their integrated ecosystem allows them to support the entire process from discovery to commercialization, setting them apart from competitors. The goal is to advance scientific breakthroughs and deliver a wide range of effective therapies.

Company Stage

Series D

Total Funding

$1.2B

Headquarters

Waltham, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

9%

1 year growth

5%

2 year growth

18%
Simplify Jobs

Simplify's Take

What believers are saying

  • ElevateBio's recent $401 million Series D financing round, led by prominent investors, positions the company for accelerated growth and innovation.
  • The collaboration with the University of Pittsburgh to build the BioForge facility will significantly expand their manufacturing capabilities and technological infrastructure.
  • Their partnerships and commercialization efforts, including potential earnouts up to $2.35 billion with Novo Nordisk, offer substantial financial and developmental opportunities.

What critics are saying

  • The highly competitive biotechnology sector requires continuous innovation and investment to maintain a leading position.
  • Dependence on strategic partnerships and collaborations may pose risks if these relationships encounter challenges or fail to deliver expected outcomes.

What makes ElevateBio unique

  • ElevateBio's integrated ecosystem of technologies and capabilities allows them to discover, develop, manufacture, and commercialize a broad spectrum of cell and gene therapies, setting them apart from competitors who may only focus on one aspect of the process.
  • Their strategic partnerships with industry leaders like Novo Nordisk and Kyverna Therapeutics enhance their technological and therapeutic development capabilities.
  • The company's proprietary technologies, such as gene editing and induced pluripotent stem cell (iPSC) platforms, provide a competitive edge in the biotechnology market.